Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377   5/09/2025
65,90 EUR (-1,64%)
(-1,64%)   5/09/2025

20 augustus 2025 · 337,000 Orion Corporation A shares converted into B shares · Persbericht

8 augustus 2025 · Orion Corporation: Managers’ transactions – Juhani Kankaanpää · Persbericht

4 augustus 2025 · Orion Corporation: Managers’ transactions – Satu Ahomäki · Persbericht

21 juli 2025 · Darolutamide receives EU approval in third indication for patients with advanced prostate cancer · Persbericht

18 juli 2025 · Orion Group Half-Year Financial Report January–June 2025 · Persbericht

18 juli 2025 · Orion Corporation’s financial reporting and Annual General Meeting in 2026 · Persbericht

9 juli 2025 · Inside information: Orion upgrades full-year outlook for 2025 · Persbericht

4 juli 2025 · Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025 · Persbericht

23 juni 2025 · 141,959 Orion Corporation A shares converted into B shares · Persbericht

20 juni 2025 · CHMP recommends third indication for darolutamide for patients with advanced prostate cancer · Persbericht

17 juni 2025 · Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs · Persbericht

3 juni 2025 · U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer · Persbericht

23 mei 2025 · Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market · Persbericht

22 mei 2025 · Orion to host Capital Markets Day today, 22 May 2025, in Helsinki · Persbericht

21 mei 2025 · Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers · Persbericht

8 mei 2025 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

7 mei 2025 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

6 mei 2025 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

5 mei 2025 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

2 mei 2025 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

Mijn selecties